Seres Therapeutics MCRB
NASDAQ MCRB
$4.57 +0.00 (+0.00%)
As of: Aug 21, 2026 · 3:59 PM EDT

Seres Therapeutics (MCRB) Inventory Average (2023 - 2024)

Seres Therapeutics (MCRB) posted Inventory Average of $47.5 million for Q2 2024, up 32.6% sequentially from $35.8 million in Q1 2024.

Seres Therapeutics (MCRB) Inventory Average (2023 - 2024) Analysis & Trends

Seres Therapeutics has reported Inventory Average for 2 years, with the latest figure at $47.5 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory Avg. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.77 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 3.09 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 213.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 707.10 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 90.57 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 196.36 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 137.65 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Seres Therapeutics 43.87 Mn 43.87 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2024 47.49 Mn
Mar 31, 2024 35.81 Mn
Dec 31, 2023 24.09 Mn
Sep 30, 2023 11.93 Mn